Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



GSK's Investigational Liver Disease Candidate Hits Primary Goal in Late-Stage Study

November 24, 2024
GSK PLC announced today that their investigational liver disease candidate has successfully achieved its primary goal in a late-stage study. The candidate has shown promising results in treating a relentless itch that affects a specific group of patients. This breakthrough has the potential to provide relief to millions of individuals suffering from this debilitating condition. GSK's commitment to developing innovative treatments for unmet medical needs is evident through this remarkable achievement. The company's dedication to improving the lives of patients is commendable. Stocks Prognosis experts recommend buying GSK's stock, as this groundbreaking news is expected to have a significant positive impact on the company's future growth.

Find out how the GSK PLC rate is expected to change

Get Forecast for GSK

Investor opinions & comments:

I wonder if there are any potential side effects of this promising treatment
— from InvestorIrene at 11-27-2024 04:13
How soon do they expect this treatment to be available for patients?
— from FinanceFrank at 11-26-2024 01:45
I'm looking forward to learning more about the specific group of patients that this candidate can help
— from DividendDaisy at 11-25-2024 01:51
I hope this breakthrough is truly effective and not just another temporary solution
— from TraderTina at 11-25-2024 00:52
This is great news! I have a family member with liver disease and this candidate could potentially help them
— from DividendDaisy at 11-24-2024 13:23
If you want to leave a comment, then you need Login or Register





Other news for GSK

GSKJune 2, 2025QuantWave Delivers 7.39% Profit with Successful GSK PLC Stock Price Target Forecast  ~2 min.

On March 21, 2025, QuantWave, the automated forecasting platform, signaled a long position for GSK PLC at a price of 38.79 $. Today, on June 2, 2025, the stock reached the predicted target price of 41....

GSKJune 2, 2025QuantWave Hits Price Target Forecast for GSK PLC, Yielding 8.78% Profit  ~1 min.

QuantWave, the automated forecasting platform, successfully achieved its price target forecast for GSK PLC, resulting in a profit of 8.78%....

GSKJune 2, 2025QuantWave Achieves GSK PLC Price Target Forecast with 6.93% Profit  ~1 min.

QuantWave, the leading automated forecasting platform, has successfully hit the price target forecast for GSK PLC, resulting in a profitable trade with a 6.93% gain....

GSKJune 2, 2025QuantWave Achieves 8.39% Profit Target Forecast for GSK PLC Stock  ~1 min.

QuantWave, an automated forecasting platform, has successfully hit a price target forecast for the stock of GSK PLC, resulting in a profit of 8.39%....

GSKJune 2, 2025QuantWave Achieves 11.28% Profit Target Forecast for GSK PLC  ~1 min.

QuantWave, the automated forecasting platform, successfully predicted a long position for GSK PLC on April 1, 2025, when the stock was trading at $37.44....



Related news

GSKJanuary 11, 2025Exciting Developments for GSK plc: Breakthrough Therapy Designation Granted for ADC  ~2 min.

GSK plc, a leading pharmaceutical company, has achieved a significant milestone in its journey towards developing breakthrough treatments....

BIIBDecember 31, 2024Biogen Inc. BIIB: Revolutionizing Healthcare with Breakthrough Research  ~2 min.

Biogen Inc. (BIIB) has emerged as a standout player in the healthcare industry, continuously pushing the boundaries of medical research and development....

GSKJanuary 1, 2025Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook  ~2 min.

GSK plc has been making remarkable strides in the field of oncology treatments and therapies, paving the way for a promising future....

PFENovember 11, 2024Pfizer Inc. Announces Groundbreaking Breakthrough in COVID-19 Treatment  ~2 min.

Pfizer Inc., the renowned pharmaceutical company, has made a groundbreaking discovery in the fight against COVID-19....

LLYJanuary 2, 2025Eli Lilly and Company Setting New Industry Standards with Revolutionary Drug Innovations  ~2 min.

Eli Lilly and Company, a leading pharmaceutical company, is making groundbreaking strides in the field of drug innovations, setting new industry standards for others to follow....